Runner up for Litigator of the Week include Winston & Strawn litigation department co-chair George Lombardi plus partners Nimalka Wickramasekera and Ivan Poullaos, who scored for Teva Pharmaceuticals and its subsidiary Actavis Elizabeth LLC in Delaware federal court. The trio convinced a jury that two of Teva’s generic medicines did not infringe Swedish drugmaker Orexo’s opioid addiction treatment drug Zubsolv. Orexo was seeking at least $41 million in damages.
It wasn’t Teva’s only win in Delaware this week. Goodwin Procter partner Elizabeth Holland represented the drug maker in a patent infringement fight against Cosmo Technologies and Valeant Pharmaceuticals that went to trial in 2017. Not only did she and her team prevail on judgment as a matter of law, she’s now convinced U.S. District Judge Leonard Stark that the case was exceptional and warrants an award of attorneys’ fees. Sweet!
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
